Clarification sought from Procter & Gamble Hygiene and Health Care Ltd
The Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd with respect to news article appearing on www.business-standard.com - August 07, 2018 titled "CCI approves P&G;'s acquisition of 51.80% stake in drug firm Merck Ltd".The reply is awaited. Procter & Gamble upbeat about Indian market as biz grows in double-digits
In India, P&G operates through two listed and one unlisted company, which together delivered a top line of Rs 90 billion for the financial year 2016-17 Board to consider Q1 result & Dividend on August 22, 2018
Procter & Gamble Hygiene and Health Care Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on August 22, 2018, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2018 (Q1) and to consider recommendation of dividend (if any). Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 22, 2018
PROCTER has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2018 ,inter alias, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 22, 2018, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2018 and to consider recommendation of dividend (if any). Certificate Under Regulation 40 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Second Half And The Financial Year Ended July 30, 2018
We are enclosing herewith the Certificate under regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for second half of the Financial Year ended June 30, 2018 furnished by a Practising Company Secretary. Shareholding for the Period Ended June 30, 2018
Procter & Gamble Hygiene and Health Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Compliance Certificate Under Regulation 7(3) For The Year Ended June 30, 2018
We enclose herewith Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015. Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Flavia MachadoDesignation :- Authorised Signatory Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
We would like to submit the notice of the Postal Ballot with respect to the Company's proposal to approve appointment of Mr. Madhusudan Gopalan as Director and Managing Director of the Company for a period of five years. Designating Chief Financial Officer As Compliance Officer Of The Company
We hereby inform you that at a meeting of the Board of Directors of the Company held today, Mr. Prashant Bhatnagar, Chief Financial Officer of the Company, has been designated as the Compliance Officer of the Company, till the vacancy of Company Secretary Position is filled.